News wire article from our research archive:

FDA to Spell Out Rules on Outside Advisers

WASHINGTON - Outside experts who advise the government on drugs and other regulated products often have financial ties to industry, creating the potential for conflicts of interest.

Bar these scientists from review panels, say some members of Congress and critics of the Food and Drug Administration. Not possible, the agency says, because so many scientists whose expertise the government relies on have ties to industries under FDA regulation.

But pressured by Congress, the agency is trying to bring its decision-making more into the open, by spelling out how and why it grants waivers for outside experts that allow them to serve as FDA advisers.

Eventually, new guidelines - plans for ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!